Literature DB >> 23400346

Aortic valve sclerosis is a high predictive marker of systemic endothelial dysfunction in hypertensive patients.

T Erdoğan1, M Cetin, S A Kocaman, M E Durakoğlugil, E Ergül, A Canga.   

Abstract

BACKGROUND: Aortic valve sclerosis (AVS) is closely related to hypertension and is an important predictor of coronary artery disease as well as cardiovascular morbidity and mortality. However, the mechanisms causing AVS have not yet been clarified. Therefore, we planned to investigate the influence of atherosclerosis-related risk factors including C-reactive protein (CRP), epicardial adipose tissue (EAT), carotid intima-media thickness (CIMT), pulse wave velocity (PWV), left ventricular hypertrophy, and the conventional risk parameters as well as endothelial dysfunction in untreated hypertensive patients. METHODS AND
RESULTS: Our study was cross-sectional and observational, and included 107 consecutive untreated hypertensive patients. All patients underwent vascular evaluation by CIMT, PWV, flow-mediated dilation (FMD%), as well as echocardiographic examinations. Age (OR = 1.180, p < 0.001), male sex (OR = 3.056, p = 0.019), waist circumference (OR = 1.082, p = 0.004), EAT (OR = 1.419, p = 0.001), smoking status (OR = 3.161, p = 0.014), FMD% (OR = 0.649, p < 0.001), mean CIMT (OR = 2.481, P < 0.001), and carotid plaque (OR = 4.692, P = 0.001) were associated with AVS in univariate analyses. Multivariate analyses revealed only age (OR = 1.144, P = 0.006) and FMD% (OR = 0.691, 0.001) as independent predictors of AVS. The presence of AVS had a high positive predictive value (100 %) but a low negative predictive value (51 %) for endothelial dysfunction (FMD < 12 %) in hypertensive patients.
CONCLUSION: Our study supports the theory that systemic endothelial dysfunction has an initial and independent effect on AVS pathogenesis. Moreover, we demonstrated that the presence of AVS in patients with hypertension predicts endothelial dysfunction, with a high positive predictive value. Thus, AVS in hypertensive patients may urge clinicians toward aggressive risk factor modification and intensive treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23400346     DOI: 10.1007/s00059-013-3763-9

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  51 in total

1.  Why is aortic sclerosis associated with adverse clinical outcomes?

Authors:  Catherine M Otto
Journal:  J Am Coll Cardiol       Date:  2004-01-21       Impact factor: 24.094

Review 2.  Valvular aortic stenosis: disease severity and timing of intervention.

Authors:  Catherine M Otto
Journal:  J Am Coll Cardiol       Date:  2006-05-15       Impact factor: 24.094

3.  Aortic valve mechanics: an emerging role for the endothelium.

Authors:  Craig A Simmons
Journal:  J Am Coll Cardiol       Date:  2009-04-21       Impact factor: 24.094

4.  The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening.

Authors:  John E Cosmi; Smadar Kort; Paul A Tunick; Barry P Rosenzweig; Robin S Freedberg; Edward S Katz; Robert M Applebaum; Itzhak Kronzon
Journal:  Arch Intern Med       Date:  2002-11-11

5.  Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves.

Authors:  M Olsson; J Thyberg; J Nilsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-05       Impact factor: 8.311

6.  Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction.

Authors:  Gianluca Iacobellis; Filippo Assael; Maria Cristina Ribaudo; Alessandra Zappaterreno; Giuseppe Alessi; Umberto Di Mario; Frida Leonetti
Journal:  Obes Res       Date:  2003-02

7.  Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties.

Authors:  J M Marchington; C A Mattacks; C M Pond
Journal:  Comp Biochem Physiol B       Date:  1989

8.  Factors associated with calcific aortic valve degeneration in the elderly.

Authors:  M Lindroos; M Kupari; J Valvanne; T Strandberg; J Heikkilä; R Tilvis
Journal:  Eur Heart J       Date:  1994-07       Impact factor: 29.983

9.  Relation of carotid intima-media thickness and aortic valve sclerosis (from the ISMIR study ["Ispessimento Medio Intimale e Rischio Cardiovascolare"] of the Italian Society of Cardiovascular Echography).

Authors:  Francesco Antonini-Canterin; Vitantonio Di Bello; Giovanni Di Salvo; Salvatore La Carrubba; Giancarlo Bellieni; Frank Benedetto; Francesco Perticone; Raffaele Maio; Danilo Giannini; Alberto Balbarini; Gian Luigi Nicolosi; Antonio Pezzano; Scipione Carerj
Journal:  Am J Cardiol       Date:  2009-04-08       Impact factor: 2.778

10.  Cardiac calcification by transthoracic echocardiography in patients with known or suspected coronary artery disease.

Authors:  Anca I Corciu; Valeria Siciliano; Elisa Poggianti; Christina Petersen; Lucia Venneri; Eugenio Picano
Journal:  Int J Cardiol       Date:  2009-02-04       Impact factor: 4.164

View more
  4 in total

1.  Olfactory ensheathing cells promote neurite sprouting of injured axons in vitro by direct cellular contact and secretion of soluble factors.

Authors:  R S Chung; A Woodhouse; S Fung; T C Dickson; A K West; J C Vickers; M I Chuah
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

2.  Link between aortic valve sclerosis and myocardial no-reflow in ST-segment elevation myocardial infarction.

Authors:  L Korkmaz; H Erkan; M T Ağaç; E Pelit; H Bektas; Z Acar; I Gurbak; F Kara; Ş Çelik
Journal:  Herz       Date:  2014-01-19       Impact factor: 1.443

Review 3.  Self-eating and Heart: The Emerging Roles of Autophagy in Calcific Aortic Valve Disease.

Authors:  Yunlong Fan; Jiakang Shao; Shixiong Wei; Chao Song; Yanan Li; Shengli Jiang
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

Review 4.  Insights into aortic sclerosis and its relationship with coronary artery disease.

Authors:  Alexandra C Milin; Gabriel Vorobiof; Olcay Aksoy; Reza Ardehali
Journal:  J Am Heart Assoc       Date:  2014-09-05       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.